Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Treasury Shares: 2019-2024

Historic Treasury Shares for Fulcrum Therapeutics (FULC) over the last 4 years, with Dec 2024 value amounting to $43,072.

  • Fulcrum Therapeutics' Treasury Shares rose 97577.75% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.5 million, marking a year-over-year increase of 97577.75%. This contributed to the annual value of $43,072 for FY2024, which is 42.58% down from last year.
  • As of FY2024, Fulcrum Therapeutics' Treasury Shares stood at $43,072, which was down 42.58% from $75,017 recorded in FY2023.
  • Fulcrum Therapeutics' 5-year Treasury Shares high stood at $76,718 for FY2022, and its period low was $43,072 during FY2024.
  • Its 3-year average for Treasury Shares is $64,936, with a median of $75,017 in 2023.
  • Data for Fulcrum Therapeutics' Treasury Shares shows a maximum YoY tumbled of 42.58% (in 2024) over the last 5 years.
  • Over the past 3 years, Fulcrum Therapeutics' Treasury Shares (Yearly) stood at $76,718 in 2022, then dropped by 2.22% to $75,017 in 2023, then slumped by 42.58% to $43,072 in 2024.